loader2
NRI

Dec 12, 2024

Category

Equity

AUM (Cr.)

1,203.23

Exit Load (%)

1.00

Min Inv Lumpsum

5,000

Expense Ratio

2.24

Sharpe Ratio

25.71

Beta Ratio

0.00

Fund Manager

Kamal Gada

Inception Date

Jun 28, 1999

Risk Level

Very High

Investment Objective

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Invest Now
Nifty Pharma

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - UTI-Healthcare Fund (G) 2.08 23.15 47.27 21.04 27.89 14.1
Benchmark - Nifty Pharma 15.17 46.96 48.33 9.19 -2.27 0
Category Average - BEST EQUITY PERFORMERS 3.96 7.88 30.49 18.84 22.72 18.34
Category Rank 6/5 7/5 6/5 7/5 7/5 5/5
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
SBI Technology Opportunities Fund (IDCW) 139.6400 0.57 39.47 13.90 29.15 4,585.67 1.89 5,000.00 invest
SBI Technology Opportunities Fund (G) 231.8886 0.57 39.47 13.90 29.13 4,585.67 1.89 5,000.00 invest
Franklin Asian Equity Fund (G) 29.1810 0.51 21.94 -1.25 4.30 245.50 0.00 5,000.00 invest
Franklin Asian Equity Fund (IDCW) 13.7740 0.51 21.94 -1.25 4.30 245.50 0.00 5,000.00 invest
Edelweiss Recently Listed IPO Fund (IDCW) 28.4394 -1.38 29.37 10.35 24.35 973.95 2.27 100.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)		 4 Months Trends
Equity-Sun Pharma.Inds. Nov 30, 2024 129.12 10.73 -3.68
Equity-Cipla Nov 30, 2024 69.13 5.75 -1.15
Equity-Ajanta Pharma Nov 30, 2024 58.35 4.85 -8.63
Equity-Dr Reddy`s Labs Nov 30, 2024 56.54 4.70 1.88
Equity-Glenmark Pharma. Nov 30, 2024 47.28 3.93 11.46
Equity-Gland Pharma Nov 30, 2024 46.28 3.85 5.26
Equity-Apollo Hospitals Nov 30, 2024 40.97 3.41 -2.76
Equity-Fortis Health. Nov 30, 2024 40.32 3.35 1.73
Equity-P & G Health Ltd Nov 30, 2024 38.31 3.18 -1.06
Equity-Divi`s Lab. Nov 30, 2024 37.95 3.15 4.81

latest news

UTI MF announces change in benchmark index under its schemes

UTI Mutual Fund has announced change in the benchmark of UTI Annual Interva...

Dec 02, 2024 11:59

UTI Conservative Hybrid Fund announces Income Distribution cum capital withdrawal (IDCW)

UTI Mutual Fund has announced IDCW is 02 December 2024 as the record date f...

Nov 28, 2024 09:29

UTI Aggressive Hybrid Fund announces Income Distribution cum Capital Withdrawal (IDCW)

UTI Mutual Fund has announced 26 November 2024 as the record date for decla...

Nov 22, 2024 09:20

UTI Conservative Hybrid Fund announces Income Distribution cum capital withdrawal (IDCW)

UTI Mutual Fund has announced IDCW is 04 November 2024 as the record date f...

Oct 30, 2024 09:20

UTI MF announces Income Distribution cum capital withdrawal (IDCW)

UTI Mutual Fund has announced 22 October 2024 as the record date for the de...

Oct 18, 2024 09:36

UTI MF announces change in benchmark index under its scheme

UTI Mutual Fund has announced change in the benchmark of UTI Floater Fund w...

Oct 03, 2024 11:12

SCHEME DETAILS

AMC Name : UTI Mutual Fund
Fund Name : UTI-Healthcare Fund (G)
Contact Persone : Kamal Gada
Registered Address : UTI Towers, Gn Block,Bandra Kurla Complex,Bandra (East), Mumbai 400 051
Telephone No : 022 66786666
Fax No. : 022 66786503;66786578
Email : service:uti.co.in
Website : www.utimf.com